Drug Eluting Stent News and Research

RSS
A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis.
Advances in clinical cardiology

Advances in clinical cardiology

Drug-eluting stent use in heart patients determined more by insurance type

Drug-eluting stent use in heart patients determined more by insurance type

First drug-eluting stent approved in Europe for most severe form of arterial disease in the leg

First drug-eluting stent approved in Europe for most severe form of arterial disease in the leg

One stent may be as good as two

One stent may be as good as two

Treatment of severe coronary artery disease with angioplasty/coronary stenting a viable alternative to bypass surgery

Treatment of severe coronary artery disease with angioplasty/coronary stenting a viable alternative to bypass surgery

Drug-eluting stents significantly cut the rates of heart attack and repeat procedures

Drug-eluting stents significantly cut the rates of heart attack and repeat procedures

Cordis patents infringed by Boston Scientific Stents

Cordis patents infringed by Boston Scientific Stents

First patient to test new treatment for peripheral arterial disease

First patient to test new treatment for peripheral arterial disease

Drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Adenosine Therapeutics awarded grant to develop drug eluting stents to prevent restenosis

Adenosine Therapeutics awarded grant to develop drug eluting stents to prevent restenosis

Sirolimus drug-coated stent causes less inflammation than bare metal stents

Sirolimus drug-coated stent causes less inflammation than bare metal stents

Early reports of thrombosis after insertion of drug-eluting stent

Early reports of thrombosis after insertion of drug-eluting stent

Coronary stent drives Johnson & Johnson to record profits

Coronary stent drives Johnson & Johnson to record profits